For example, GLP-1RAs such as exendin-4 (exenatide) have shown the ability to restore striatal dopamine levels, preserve tyrosine hydroxylase-positive neurons, and alleviate motor deficits in PD animal models [10,11]. This evidence concerns the gene TH and Parkinson disease.